This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Feb. 5, 2013 /PRNewswire/ -- dailyRx News announced today the most popular health topics viewed and shared during January 2013. dailyRx News publishes and syndicates consumer-centric health information across affiliated websites, YouTube, various news aggregators, and to patients through a national network of healthcare providers' social media channels.
"dailyRx News reports on medication and health research distributed by the FDA, medical schools, and clinical trials," said
Donald W. Hackett, CEO and Publisher of dailyRx News. "dailyRx's reporters and medical editors understand the importance of translating medical terminology into information that everyone can understand. We focus on publishing content that is timely, accurate, and actionable," Hackett added.
According to the Pew Research Center's Internet & American Life Project, 35% of American adults have searched the web specifically to learn about a medical condition they or someone they know might have. "With an increasing number of Americans accessing digital information for initial self-diagnosis purposes, there is no room in today's news industry for outdated information, biased research, or reader confusion," Hackett said.
Health conditions generating notable viewer engagement on dailyRx.com last month included:
About The dailyRx News Network
The dailyRx News Network is an emerging leader in publishing health news for consumers and patients alike. dailyRx publishes, aggregates, and syndicates doctor-reviewed news covering a wide range of health conditions, medications, over-the-counter products, and nutraceutical compounds. dailyRx's original content is written in positive, unbiased, easy-to-understand language and reviewed for accuracy by doctors, pharmacists, and therapists.
dailyRx, Inc. is a
Patient Conversation Media, company.
SOURCE dailyRx News